Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 6, 2011, Pages 737-743

  Downs Kelly, Erinn ^a   Bell, Diana ^a   Perkins, George H ^a   Sneige, Nour ^a   Middleton, Lavinia P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG CARCINOMA; MASTECTOMY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME;

EID: 79958787634     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dixon JM, Anderson TJ, Page DL, et al. Infiltrating lobular carcinoma of the breast. Histopathology. 1982; 6(2): 149-161. (Pubitemid 12150073)
2. Page DL, Jefferson TJ. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone; 1988: 219-226.
3. Fechner RE. Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol. 1975; 6(3): 373-378.
4. Foote FW Jr, Foote FW Sr. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol. 1941; 17(4): 491-496.
5. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979; 3(6): 467-488. (Pubitemid 10201560)
6. Wheeler JE, Enterline HT. Lobular carcinoma of the breast in situ and infiltrating. Pathol Annu. 1976; 11: 161-188. (Pubitemid 8095844)
7. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologie-pathologie correlation. AJR Am) Roentgenol. 2001; 176(5): 1255-1259.
8. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000; 436(5): 421-430. (Pubitemid 30312157)
9. Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol Case Rev. 1996; 1: 27-31.
10. Shin SJ, DeLellis RA, Knowles DM, et al. "Florid" lobular carcinoma in situ with necrosis and calcification: a clinicopathologic, immunohistochemical and molecular analysis [abstract]. Mod Pathol. 2002; 15:52A.
11. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002; 15(10): 1044-1050.
12. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000; 24(12): 1650-1656.
13. Chen YY, Hwang ES, Roy R, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009; 33(11): 1683-1694.
14. Bratthauer GL, Moinfar F, Stamatakos MD, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol. 2002; 33(6): 620-627. (Pubitemid 34827543)
15. Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of Ecadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer. 2001; 92(4): 738-747. (Pubitemid 32783057)
16. Jacobs TW, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001; 25(2): 229-236. (Pubitemid 32167505)
17. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol. 2001; 25(2): 237-244. (Pubitemid 32167506)
18. Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol. 2007; 31(3): 427-437. (Pubitemid 46673117)
19. Dabbs DJ, Kapali M, Chivukula M, et al. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol. 2007; 15(3): 260-266. (Pubitemid 47329916)
20. Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol. 1998; 11(9): 814-822. (Pubitemid 28440877)
21. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. Pathol. 2005; 207(1): 1-13. (Pubitemid 41200708)
22. Page, DL, Schuyler PA, Dupont WD, Jensen RA, Pummer WD Jr, Simpson JF. Atypical lobular hyperplasia as an unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003: 361(9352): 125-129. (Pubitemid 36092016)
23. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl) Med. 1993; 328(22): 1581-1586.
24. Fisher ER, Costantino J, Fisher B, et al The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer. 1995; 75(6): 1310-1319.
25. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999; 86(3): 429-438. (Pubitemid 29347405)
26. Julien JP, Bijker N, Fentiman IS, et al EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet. 2000; 355(9203): 528-533. (Pubitemid 30088672)
27. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol. 1999; 173(2): 291-299. (Pubitemid 29347344)
28. Middleton LP, Grant S, Stephens T, et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003; 16(2): 120-129. (Pubitemid 36245743)
29. O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy-what is the clinical significance? Clin Radiol. 2001; 56(3): 216-220.
30. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2006; 30(11): 1445-1453. (Pubitemid 44655481)
31. Chivukula M, Haynik DM, Brufsky A, et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies. Am J Surg Pathol. 2008; 32(11): 1721-1726.